Ezrin seems to be associated with Rac1 activation when glomerular podocytes are injured, and the suppression of ezrin expression might thus be beneficial for protection of proteinuria in glomerulopathies. The gene discussed is EZR; the disease is lipoprotein glomerulopathy.